# Immix Biopharma, Inc.: Form 8-K/A, filed Mar 13, 2023

- Company: [Immix Biopharma, Inc.](/companies/immx.md) (CIK 1873835)
- Form: 8-K/A
- Filed: 2023-03-13
- Accepted by EDGAR: Mar 13, 2023, 06:05 ET
- Period: 2023-03-10
- Accession: 0001493152-23-007317
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/form8-ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/form8-ka.htm

Filed Mar 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-007317. Last ingested by Listed: Nov 13, 2026, 15:56 ET. No prices; not investment advice.
